Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for a human Toxoplasma vaccine.

D T Bout1, M N Mevelec, F Velge-Roussel

  • 1UFR de UMR Université-INRA d'Immunologie Parasitaire, Pharmacie Tours, 31 Av. Monge, F-37200 Tours, France. bout@univ-tours.fr

Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|December 13, 2002
PubMed
Summary

A novel vaccine strategy aims to prevent human toxoplasmosis by targeting the gut's immune system. This approach focuses on stimulating mucosal immunity to block parasite entry and protect against severe disease, especially in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIGO Gene Variants: New Insights Into Prenatal Diagnosis.

Prenatal diagnosis·2025
Same author

Effectiveness of SplashGuard Caregiver prototype in reducing the risk of aerosol transmission in intensive care unit rooms of SARS-CoV-2 patients: a prospective and simulation study.

The Journal of hospital infection·2023
Same author

The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.

Digestive diseases and sciences·2022
Same author

Bayesian latent class analysis of the characteristics of diagnostic tests to assess the passive immunity transfer status in neonatal Belgian Blue beef calves.

Preventive veterinary medicine·2022
Same author

Transfer kinetics of labeled aroma compounds from liquid media into coffee beans during simulated wet processing conditions.

Food chemistry·2020
Same author

Potential use of biochar, compost and iron grit associated with Trifolium repens to stabilize Pb and As on a multi-contaminated technosol.

Ecotoxicology and environmental safety·2019

Area of Science:

  • Immunology
  • Vaccinology
  • Parasitology

Background:

  • Human toxoplasmosis, caused by *Toxoplasma gondii*, is typically mild but can cause severe or fatal outcomes in immunocompromised individuals or during fetal transmission.
  • The oral route is the primary infection pathway, necessitating a mucosal immune response to prevent parasite invasion.

Purpose of the Study:

  • To propose a vaccine strategy that elicits a protective immune response at the mucosal level against *Toxoplasma gondii* infection.
  • To identify key immune components (CD8 T cells, IgA antibodies) and cellular targets (mucosal dendritic cells) for an effective vaccine.

Main Methods:

  • The study hypothesizes a vaccine combining an optimized synthetic antigen (subunit, DNA, or replicon) with an adjuvant.
  • The proposed vaccine delivery system involves inert polymer microparticles to target mucosal dendritic cells via M cells in the gut or nasal-associated lymphoid tissues.

Related Experiment Videos

Main Results:

  • The abstract does not contain specific experimental results but outlines a hypothesis for vaccine development.
  • The strategy aims to stimulate both cellular (CD8 T cells) and humoral (IgA) arms of the mucosal immune system.

Conclusions:

  • An effective human vaccine for toxoplasmosis should target mucosal immunity to prevent initial parasite invasion.
  • Utilizing polymer microparticles to deliver antigens and adjuvants to mucosal dendritic cells is a promising approach for inducing protective immunity.